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The aim of this study was to evaluate the effects of two registered herbal drugs called IMOD and Angipars on
mouse model. Aging was induced by D-galactose (500 mg/kg) administered to animals for 6 weeks through
drinking water. Male BALB/c mice were randomly divided into 5 groups receiving D-galactose (D-galactose,
500 mg/kg) for 6 weeks; positive control (D-galactose [500 mg/kg] for 6 weeks + Vitamin E [200 mg/kg/day]
intraperitoneally for 4 weeks); IMOD (D-galactose [500 mg/kg] for 6 weeks + IMOD [20 mg/kg/day] intraperitoneally
for 4 weeks), Angipars (D-galactose [500 mg/kg] for 6 weeks + Angipars [2.1 mg/kg/day] by gavage for 4 weeks);
and the fifth group that was sham and not given D-galactose. At the end of treatment, pro-inflammatory markers
including tumor necrosis factor-α (TNF-α), interlukine-1β (IL-β), interlukine-6 (IL-6), Nuclear Factor-kappaB (NF-κb),
total antioxidant power (TAP), lipid peroxides (LPO) and male sex hormones i.e. testosterone and
dehydroepiandrosterone-sulfate (DHEA-S) were measured in the blood.
Results showed that D-Galactose induces a significant oxidative stress and proinflammatory cascade of aging while
both IMOD and Angipars recovered all of them. Interestingly, IMOD and Angipars were better than Vitamin E in
improving male sex hormones in aged mice. This effect is so important and should be considered as an advantage
although it cannot be explained with current knowledge. The conclusion is that IMOD and Angipars have marked
anti-aging effect on D-galactose-induced model of aging.
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Use of natural medicines was increased in the world
because of their lower adverse effects, price and good
efficacy in most human illnesses [1-3]. Recent experi-
mental and clinical studies have confirmed anti-aging
effects of some traditionally-used herbs [4]. In the
recent years, the novel registered drug named (IMOD)
has shown positive effects on reduction of oxidative
stress and pro-inflammatory status in various studies
[5]. IMOD is a combination of ethanolic extracts of
Rosa canina, Tanacetum vulgare and Urtica dioica that
are combined with selenium and urea and then exposed
to a pulsed electromagnetic field [6]. Angipars is also a* Correspondence: mohammad@tums.ac.ir
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reproduction in any medium, provided the orregistered drug derived from a plant named Melilotus
officinalis under electromagnetic processes which has
marked antioxidant effects and is used as a drug of
choice for management of human diabetic foot [7,8].
Both IMOD and Angipars have been approved by Iran-
ian Food and Drug Organisation for their main effects
including human immunodeficiency syndrome and dia-
betic foot, respectively.
Aging as an extremely complex biological phenomenon
is demonstrated by accumulation of deleterious changes
during the time with an increase in the chance of disease
and death. The free radical and oxidative stress theory of
aging is recognized as one of the most plausible and
promising explanations for the process of aging [9]. Aging
is associated with dysregulated immune system, weakened
sex hormones and increased amount of oxidative stress
markers or inflammatory cytokines.
In the present study, a typical mouse D-galactose-
induced model of aging with some modifications wasal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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levels is converted to aldose and hydroperoxide under the
catalysis of galactose oxidase, resulting in the generation of
a superoxide anion and oxygen-derived free radicals [10].
These changes are considerably similar to the normal aging
process and similar to natural senescence model demon-
strating neurological impairment, decreased activity of anti-
oxidant enzymes, and poor immune responses [11,12].
Thus, given the knowledge of the antioxidant and
anti-inflammatory potential of IMOD and Angipars, and
the pathophysiology of aging, the present study was




Thiobarbituric acid (TBA), trichloroacetic acid (TCA),
n-butanol, hexadecyltrimethyl ammonium bromide
(HETAB), tri (2-pyridyl)-s-triazine (TPTZ), HCl, malon-
dialdehyde (MDA), ferric chloride (FeCL3-6H2O),
D-galactose, and vitamin E (Trolox) were purchased
from Merck chemical Co. (Germany). Rat specific
tumor necrosis factor-α (TNF-α), interlukine-1β (IL-β),
interlukine-6 (IL-6), Nuclear Factor-kappaB (NF-κb) ELISA
kits were purchased from BenderMed Systems Inc.
(Austria). Testosterone and dehydroepiandrosterone ELISA
kits were purchased from Dia Metra (Italy). IMOD and
Angipars were obtained from Parsrus Research Group
(Iran).
Animals
Male BALB/c mice (3 months old, 18–22 g) were pro-
vided from Tehran University of Medical Sciences
(TUMS) animal house. The animals were housed in
standard polypropylene cages with wired-net top in a
controlled room (temperature 23 ± 1°C, humidity
55 ± 10%, 12-h light–dark cycle and were allowed free
access to standard laboratory pellet diet and water dur-
ing the experiments. All ethical issues on the use of ani-
mals were carefully considered and the study protocol
was approved by TUMS review board with code number
of 90-03-33-15668.
Experimental design
Before starting the main study, a pilot was designed to
set up aging model and to get proper doses of treat-
ments. In the main study, fifty mice were randomly
divided into five groups, each consisting of 10 animals.
D-galactose was dissolved in a measured quantity of
mice drinking water. D-galactose was given to four out
of five groups of animals at 500 mg/kg D-galactose per
10 ml drinking water for 6 weeks [13,14]. The fifth
group of animals was the sham group which was not
given D-galactose. After 2 weeks, the four groups whichhad been given D-galactose were randomly divided into
aging control group (500 mg/kg D-galactose per 10 ml
drinking water, for 4 weeks), positive control group
(500 mg/kg D-galactose per 10 ml drinking water plus
vitamin E 200 mg/kg/day intraperitoneally for 4 weeks)
and IMOD treatment group (500 mg/kg D-galactose per
10 ml drinking water plus IMOD 20 mg/kg/day intraper-
itoneally for 4 weeks), and Angipars treatment group
(500 mg/kg D-galactose per 10 ml drinking water plus
Angipars 2.1 mg/kg/day by gavage for 4 weeks).
Twenty-four hours after the last drug administration,
blood samples were taken of each animal under
anesthesia by cardiac puncture. Serum samples were
obtained by centrifuging the whole blood at 1000 × g at
4°C for 10 minutes and the supernatants were trans-
ferred into several microtubes for separate biochemical
assays and maintained at −80°C until the analyses were
performed. Biochemical markers including TNF-α, IL-β,
IL-6, NF-κb, ferric reducing/total antioxidant power (TAP),
lipid peroxidation (LPO) marker and male sex hormones
including testosterone and dehydroepiandrosterone-sulfate
(DHEA-S) were measured in the serum.Measurement of LPO in serum of D-galactose-induced
aged mice
LPO was measured by the reaction of TBA with MDA
and other lipid peroxides. Samples were mixed with
TCA (20%) and the precipitate was dispersed in H2SO4
(0.05 M). After addition of TBA (0.2% in sodium sul-
fate), the sample was heated for 30 min in a boiling
water bath. Then LPO adducts were extracted by n-
butanol and absorbance was measured at 532 nm as
described in details in our previous work [15]. Data
were expressed as nM.Measurement of TNF-α, IL-1β, IL-6 and NF-κb levels in
serum of D-galactose-induced aged mice
Quantitative detection of TNF-α, IL-1β, IL-6 and NF-κb
levels in serum were performed using an enzyme-linked
immunosorbaent assay rat specific ELISA kit. The ab-
sorbance of the final colored product was measured in
450 nm as the primary wave length and 620 nm as the
reference wave length. TNF-α, IL-1β, IL-6 and NF-κb
levels were expressed as pg/mg.Measurement of TAP in the serum of D-galactose-induced
aging mice
Serum TAP was evaluated by measuring the ability to re-
duce Fe3+ to Fe2+. Interaction of TPTZ with Fe2+ results
in formation of a blue color with a maximum absorb-
ance at 593. The whole procedure has been described in
our previous study [16]. Data were expressed as mM.
Figure 1 Effects of IMOD and Angipars in serum lipid peroxidation (LPO) of D-galactose (D-Gal)-induced aged mice. Data are mean ±
SEM of ten animals.
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of D-galactose-induced aged mice
For determination of testosterone and DHEA-S, we used
ELISA kits and did as instructed by the kit brochure. Tes-
tosterone and DHEA-S levels were expressed as ng/ml.Statistical analysis
Results are expressed as mean ± standard error of the
mean (SEM). Data were analyzed by one-way ANOVA
followed by Tukey post-hoc test for multiple compari-
sons to ensure the variances of the data are distributed
properly. A p-value less than 0.05 was considered
significant.Figure 2 Effects of IMOD and Angipars in serum total antioxidant pow
mean ± SEM of ten animals.Results
Effects of IMOD and Angipars on LPO of aged mice
The level of changes in LPO in different studies is
demonstrated in Figure 1. A significant increase in LPO
is evident in aged animals when compared to sham
(4.6 ± 0.19 vs. 2.9 ± 0.12, P = 0.001). D-galactose-induced
elevation of LPO was significantly restored following
treatment with IMOD (3.6 ± 0.12 vs. 4.6 ± 0.19, P = 0.012),
Angipars (3.17 ± 0.29 vs. 4.6 ± 0.19, P = 0.001), and vitamin
E (3.2 ± 0.45 vs. 4.6 ± 0.19, P = 0.001).
Effects of IMOD and Angipars on TAP of aged mice
As shown in Figure 2, TAP in aged animals is lower
than that in the sham group (544 ± 14.8 vs. 421 ± 11.3,er (TAP) of D-galactose (D-Gal)-induced aged mice. Data are
Figure 3 Effects of IMOD and Angipars in serum interleukin-1 beta (IL-1β) of D-galactose (D-Gal)-induced aged mice. Data are mean ±
SEM of ten animals.
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significantly recovered following treatment with IMOD
(692 ± 49.2 vs. 421 ± 11.3, P = 0.001), Angipars (590 ± 54.9
vs. 421 ± 11.3, P = 0.05), and vitamin E (570 ± 44 vs.
421 ± 11.3, P = 0.05).
Effects of IMOD and Angipars on TNF-α, IL-6, IL-1β and
NF-kB of aged mice
Figures 3, 4, 5 and 6 respectively show the effects of
aging on the levels of TNF-α, IL-6, IL-1β, and NF-kBFigure 4 Effects of IMOD and Angipars in serum tumor necrosis facto
are mean ± SEM of ten animals.in comparison to sham group (121 ± 9.8 vs. 79.6 ± 3.67,
P = 0.003; 750 ± 77 vs. 358 ± 17.85, P = 0.001; 73.6 ± 1.7
vs. 43.18 ± 6.7, P = 0.001; 6.9 ± 0.73 vs. 3.9 ± 0.04,
P = 0.001). Administration of IMOD (58 ± 5.2 vs. 121 ±
9.8, P = 0.005; 480 ± 59.8 vs. 750 ± 77, P = 0.001; 38 ± 3.5
vs. 73.6 ± 1.7, P = 0.001; 4.2 ± 0.27 vs. 6.9 ± 0.73, P = 0.001),
Angipars (72.1 ± 5.02 vs. 121 ± 9.8, P = 0.059; 477 ± 50 vs.
750 ± 77, P = 0.001; 50.8 ± 3.9 vs. 73.6 ± 1.7, P = 0.001;
4.2 ± 0.12 vs. 6.9 ± 0.73, P = 0.001) and Vitamin E (67 ± 9.4
vs. 121 ± 9.8, P = 0.002; 360 ± 5.9 vs. 750 ± 77, P = 0.001;r-alpha (TNF-α) of D-galactose (D-Gal)-induced aged mice. Data
Figure 5 Effects of IMOD and Angipars in serum interleukin 6 (IL-6) of D-galactose (D-Gal)-induced aged mice. Data are mean ± SEM of
ten animals.
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P = 0.001), respectively, recovered D-galactose-induced
increase in TNF-α, IL-6, IL-1β and NF-kB of aged mice.Effects of IMOD and Angipars on sex hormone levels of
aged mice
Testosterone (Figure 7) in aged mice was lower than
that in the sham group (0.25 ± 0.01 vs. 0.43 ± 0.05,
P = 0.000). IMOD and Angipars increased testosterone,
respectively (0.63 ± 0.1 vs. 0.25 ± 0.01, P = 0.001), and
(0.55 ± 0.04 vs. 0.25 ± 0.01, P = 0.038). DHEA-S (Figure 8)
in aged mice was lower than that in the sham groupFigure 6 Effects of IMOD and Angipars in serum NF-kappaB (NF-kB) o
ten animals.(0.89 ± 0.02 vs. 1.3 ± 0.06, P = 0.001). IMOD and Angipars
recovered both testosterone and DHEA-S in aged mice
(1.4 ± 0.14 vs. 0.89 ± 0.02, P = 0.05), and (1.31 ± 0.08 vs.
0.89 ± 0.02, P = 0.034), respectively. Vitamin E could not
significantly recover testosterone and DHEA-S values in
aged mice when compared to aged mice (0.37 ± 0.08 vs.
0.25 ± 0.01, P = 0.09) and (1 ± 0.07 vs. 0.89 ± 0.02,
P = 0.1), respectively.Discussion
In the present study, we showed for the first time
the anti-aging potentials of IMOD and Angipars.f D-galactose (D-Gal)-induced aged mice. Data are mean ± SEM of
Figure 7 Changes in serum testosterone of D-galactose (D-Gal)-induced aged mice. Data are mean ± SEM of ten animals.
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tive stress status and proinflammatory cytokines of aged
mice. Also, the present study confirmed that generation
of free radicals that causes up-regulation of pro-
inflammatory cytokines is a major determinant involved
in the D-galactose-induced aging model. We explored
that IMOD and Angipars exert their effects mainly
through strong antioxidative potential and enhancing
TAP and reduction of LPO. Interestingly, present results
indicated improvement of testosterone and DHEA-S by
IMOD and Angipars in the aged mice. Decline ofFigure 8 Changes in serum dehydroepiandrosterone-sulfate of D-gala
animals.steroid hormones with aging is already known and is
believed a major contributor to elevation of pro-
inflammatory markers [16,17]. Supporting the mechan-
ism of action of IMOD and Angipars, and the theory of
oxidative stress in aging, vitamin E showed the similar
effects in examined markers of aging.
The herbs used in the IMOD complex have strong
anti-oxidative stress potential that is useful in many
oxidant-related diseases [1]. IMOD with its mechanism of
action has been found useful in oxidative-stress-related
disorders and immunoinflammatory-based diseases likectose (D-Gal)-induced aged mice. Data are mean ± SEM of ten
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islet transplant [20] and polycystic ovary syndrome [21].
In addition, IMOD has been found safe in preclinical
[22] and clinical studies [23] that favors its advantages
if supplemented chronically to those getting old.
On the other hand, Angipars has been studied in all
steps of clinical trial and was recently presented as a
novel treatment for diabetic foot ulcers, with a possible
mechanism of angiogenesis [24-26]. In aging the process
of angiogenesis is disturbed and thus Angipars might
act through increasing angiopoietins that are essential
contributions to the maturation, stabilization, and re-
modeling of the vasculature. Angiogenesis is one of the
mechanisms that responsible in the wound healing
process and is declined in aging [27,28].
Interestingly, IMOD and Angipars were better than
vitamin E in improving male sex hormones that are
declined in aged mice. This effect is so important and
should be considered as an advantage although it cannot
be explained with current knowledge. This means that
IMOD and Angipars are possibly acting with mechan-
isms rather than antioxidant effects that remain to be
elucidated in further studies. Meanwhile, the combin-
ation of IMOD and Angipars should be trialed in clinic.Conclusion
The findings signify the potential of IMOD and Angipars
as a promising source of natural antioxidants in aging.Competing interests
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